STERIS CFO has 99 shares withheld for taxes

STERIS plc reported that Sr.

Rhea-AI Filing Summary

STERIS plc reported that Sr. Vice President and CFO Karen L. Burton had 99 ordinary shares withheld on June 1, 2026 to cover tax obligations on vested restricted stock. The Form 4 classifies this as a tax-withholding disposition, not an open-market trade.

The 99 shares were withheld from 340 restricted shares that vested on that date, valued at the NYSE closing market price. After this transaction, Burton directly holds 8,205 ordinary shares, of which 5,139 are restricted with scheduled lapses through October 1, 2028.

Insider Trade Summary

Exercise Price or Tax Liability: 99 shares

Exercise Price or Tax Liability 1 txn

Insider Burton Karen L

Role Sr. Vice Pres., CFO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Ordinary Shares	99	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 8,205 shares (Direct)

Footnotes (2)

1. F1. 99 shares were withheld from the 340 restricted shares that vested on June 1, 2026. These 99 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026.
2. F2. As of June 1, 2026, 5,139 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 225 on June 2, 2026; 651 on June 3, 2026; 306 on June 4, 2026; 783 on October 1, 2026; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 651 on June 5, 2028 and 783 on October 1, 2028.

Key Figures

Tax-withheld shares: 99 shares Vested restricted shares: 340 shares Post-transaction holdings: 8,205 shares +4 more

7 metrics

Tax-withheld shares 99 shares Withheld for taxes on June 1, 2026

Vested restricted shares 340 shares Restricted shares vesting on June 1, 2026

Post-transaction holdings 8,205 shares Ordinary shares held directly after transaction

Restricted shares outstanding 5,139 shares Restricted ordinary shares as of June 1, 2026

Near-term vesting tranche 225 shares Restrictions lapse on June 2, 2026

Subsequent vesting tranche 651 shares Restrictions lapse on June 3, 2026

Later vesting tranche 783 shares Restrictions lapse on October 1, 2028

Key Terms

restricted shares, taxes required to be withheld, NYSE closing market price, restrictions on these ordinary shares lapse

4 terms

restricted shares financial

"99 shares were withheld from the 340 restricted shares that vested on June 1, 2026."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

taxes required to be withheld financial

"These 99 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws."

NYSE closing market price financial

"These vested shares were valued at the NYSE closing market price on June 1, 2026."

restrictions on these ordinary shares lapse financial

"The restrictions on these ordinary shares lapse as follows: 225 on June 2, 2026; 651 on June 3, 2026; 306 on June 4, 2026; 783 on October 1, 2026; ..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did STERIS (STE) CFO Karen L. Burton report in this Form 4?

Karen L. Burton reported a tax-withholding disposition of 99 STERIS ordinary shares. These shares were withheld to satisfy taxes on 340 restricted shares that vested on June 1, 2026, rather than sold in the open market.

How many STERIS (STE) shares were withheld for taxes in this filing?

The filing shows 99 ordinary shares were withheld for taxes. They came from 340 restricted shares that vested on June 1, 2026, and were valued at the NYSE closing market price on that date as determined by the issuer.

How many STERIS (STE) shares does the CFO hold after this transaction?

After the transaction, the CFO directly holds 8,205 ordinary shares of STERIS. According to the disclosure, 5,139 of these shares are still restricted and will vest in stages through October 1, 2028, if conditions are met.

Is the STERIS (STE) CFO’s Form 4 transaction a market sale of shares?

No, the Form 4 describes a tax-withholding disposition, not an open-market sale. The 99 shares were withheld by the issuer to cover required taxes on vested restricted stock, a common administrative step in equity compensation.

What restricted share vesting schedule is disclosed for STERIS (STE) CFO Burton?

As of June 1, 2026, 5,139 ordinary shares are restricted. Restrictions lapse on specific dates between June 2, 2026 and October 1, 2028, in installments such as 225, 651, 306, 783 shares and similar amounts on listed dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burton Karen L

(Last) (First) (Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. Vice Pres., CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/01/2026		F		99(1)	D	$0	8,205(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 99 shares were withheld from the 340 restricted shares that vested on June 1, 2026. These 99 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026.

2. As of June 1, 2026, 5,139 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 225 on June 2, 2026; 651 on June 3, 2026; 306 on June 4, 2026; 783 on October 1, 2026; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 651 on June 5, 2028 and 783 on October 1, 2028.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)